Old Web
English
Sign In
Acemap
>
authorDetail
>
Philip Leese
Philip Leese
Amgen
Medicine
Pharmacokinetics
Placebo
Palifermin
Anesthesia
4
Papers
36
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers
2006
Clinical Pharmacology & Therapeutics
Parnian Zia‐Amirhosseini
Margaret Salfi
Philip Leese
Wayne Yates
Dimitry Michael Danilenko
Brian D. Ring
Alessandra Cesano
John T. Sullivan
Show All
Source
Cite
Save
Citations (26)
Pharmacokinetics (PK) and Pharmacodynamics (PD) of Palifermin (a r-huKGF molecule) in Healthy Volunteers after Intravenous Administration of Single Escalating Doses up to 250 mcg/kg.
2004
Blood
Parnian Zia‐Amirhosseini
Margaret Salfi
Philip Leese
John T. Sullivan
Show All
Source
Cite
Save
Citations (2)
A phase i safety, pharmacokinetic, and pharmacodynamic study of ascending single, oral doses of ICA-17043, a novel gardos channel inhibitor for the treatment of sickle cell disease
2000
Blood
Greg C. Rigdon
Jonathan W. Stocker
Grant McNaughton-Smith
Heyward Hull
Philip Leese
Show All
Source
Cite
Save
Citations (6)
1